Finance

Beta
Lists
9240:TYO
Delivery Consulting Inc
¥449.00
-0.44%
(-2.00) 1D
May 29, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 9240...
Open
¥459
High
¥459
Low
¥446
Mkt. cap
2.18B
Avg. vol.
12.68K
Volume
6.80K
P/E ratio
16.73
52-wk high
¥1,320
52-wk low
¥352
EPS
¥27
No. of employees
191
Open
¥459
High
¥459
Low
¥446
Mkt. cap
2.18B
Avg. vol.
12.68K
Volume
6.80K
P/E ratio
16.73
52-wk high
¥1,320
52-wk low
¥352
EPS
¥27
No. of employees
191
News stories
From sources across the web
About Delivery Consulting Inc
CEO-
Employees191
FoundedApr 10, 2003
Headquarters-
SectorInformation technology consulting
Websitedeliv.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Revenue
705.00M
740.00M
709.00M
749.00M
Cost of goods sold
415.00M
461.00M
430.00M
454.00M
Cost of revenue
415.00M
461.00M
430.00M
454.00M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
250.00M
255.00M
223.00M
212.00M
Operating expense
250.00M
255.00M
223.00M
212.00M
Total operating expenses
665.00M
716.00M
653.00M
666.00M
Operating income
40.00M
24.00M
56.00M
83.00M
Other non operating income
8.00M
1.00M
4.00M
-1.00M
EBT including unusual items
46.00M
24.00M
61.00M
86.00M
EBT excluding unusual items
46.00M
24.00M
61.00M
86.00M
Income tax expense
16.00M
7.00M
20.00M
26.00M
Effective tax rate
34.78%
29.17%
32.79%
30.23%
Other operating expenses
-
-
-
-
Net income
30.00M
17.00M
41.00M
60.00M
Net profit margin
4.26%
2.30%
5.78%
8.01%
Earnings per share
-
-
-
-
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
45.25M
29.00M
61.00M
87.50M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer